AstraZeneca Announces Initiation Of Phase III Trial With BREZTRI

(RTTNews) - AstraZeneca announced the initiation of THARROS, a Phase III trial to investigate the potential effect of triple-combination inhaled therapy BREZTRI AEROSPHERE on severe cardiopulmonary outcomes, in people with chronic obstructive pulmonary disease who also have elev https://www.nasdaq.com/articles/astrazeneca-announces-initiation-of-phase-iii-trial-with-breztri